Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Clinical Immunology · Inborn Errors of Immunity

What Is the Difference Between GOF and LOF Mutations?

At a Glance

Gain-of-function mutations increase, mistime, or change a protein’s activity, while loss-of-function mutations reduce it. Either type can cause infections or inflammation, so an exact variant must be interpreted with clinical evidence by an immunologist and genetic counselor.

When you read your genetic testing results, you might see mutations described as either “loss-of-function” or “gain-of-function.” These terms describe the molecular behavior of a genetic change—meaning how the change affects a specific protein’s activity. A loss-of-function (LOF) mutation means that a piece of the immune system is missing or does not work as well as it should, generally leading to a weakened defense [1]. A gain-of-function (GOF) mutation means that a piece of the immune system has increased activity, acts at the wrong time, or does something entirely new, often leading to a hyperactive immune response and inflammation [1].

The Security System Analogy

Think of your immune system as a home security system:

  • Loss-of-function is often like a broken motion sensor [2]. The system fails to detect intruders, making the home vulnerable to break-ins (infections).
  • Gain-of-function is often like an alarm stuck in the “on” position [3]. It blares constantly, causing chaos (inflammation) and making it difficult to mount a proper, organized response.

Important Caveat: This is only a rough guide. Depending on exactly which gene is affected, a GOF/LOF label does not guarantee a specific set of symptoms [4]. An LOF mutation can sometimes cause severe inflammation, and a GOF mutation can cause severe infections [4].

Loss-of-Function: The Missing Piece

Many Inborn Errors of Immunity (IEI)—the broader medical term encompassing primary immunodeficiencies and immune dysregulation disorders—involve LOF mutations [1]. Because the genetic instructions are misspelled, the body either doesn’t make the protein at all, or makes a defective version [1]. For example, a specific LOF mutation in the STAT1 gene breaks a key pathway needed to fight mycobacteria, leaving patients highly vulnerable to those specific infections [3].

Gain-of-Function: The Hyperactive Piece

It might sound like “gaining” a function would make your immune system stronger, but in immunology, it usually means the system is overreacting [1]. Patients with GOF mutations often experience immune dysregulation, which can include autoimmunity (the immune system attacking healthy tissues) and lymphoproliferation (an abnormal accumulation of immune cells that can cause an enlarged spleen or lymph nodes) [5] [6].

Why do GOF mutations still cause infections?
Overactive signaling can disrupt how specific immune cells develop or function. For example, GOF mutations in the STAT1 gene don’t just cause autoimmunity; they specifically impair the body’s ability to fight fungal infections [3]. The hyperactive pathway disrupts normal cellular development, preventing the body from mounting a proper antifungal defense [7].

Nuance: When Losing a Brake Causes Hyperactivity

Sometimes, losing a function paradoxically causes a hyperactive immune response [4]. This happens when the broken protein was supposed to act as a “brake” or inhibitor for the immune system.

For instance, Activated PI3K-delta Syndrome (APDS) is an IEI featuring combined immunodeficiency and autoimmunity [8]. It can be caused by a gain-of-function mutation in a gene that turns the pathway on (like PIK3CD), OR by a loss-of-function mutation in a gene that acts as a brake on the pathway (like PIK3R1) [9]. In both cases, the end result is the same: an immune pathway that is hyperactive [5].

Reading Your Lab Report: Mechanism vs. Evidence

It is crucial to understand that a “functional label” (GOF/LOF) is not the same as a clinical diagnosis [10]. Your report tells you three different things:

Report Term What It Means
The Variant The exact genetic spelling change found in your DNA.
The Functional Mechanism How the lab predicts or tests that the protein behaves (e.g., LOF, GOF) [11].
The Clinical Classification How much evidence exists that this specific variant actually causes disease [12].

A Variant of Uncertain Significance (VUS) means there isn’t enough evidence to know if the genetic change causes your symptoms [12]. Even if a lab predicts a VUS has a “gain-of-function” effect, a VUS should not be used alone to start targeted treatments, alter your care, or make testing decisions for your family [10]. Your exact gene, variant, inheritance pattern, and clinical history must all be interpreted together by an immunologist and a certified genetic counselor [13] [14].

Common questions in this guide

What does a loss-of-function mutation mean in immunology?
A loss-of-function mutation reduces or removes a protein’s normal activity. In the immune system, this can weaken protection against infections, although losing an immune “brake” can instead cause excessive inflammation.
What does a gain-of-function mutation do to the immune system?
A gain-of-function mutation increases a protein’s activity, turns it on at the wrong time, or gives it a new activity. This may cause overactive immune signaling, autoimmunity, or abnormal buildup of immune cells, but some gain-of-function changes also cause infections.
Can a gain-of-function mutation still cause infections?
Yes. An overactive immune pathway can interfere with the development or function of specific immune cells, leaving the body unable to fight certain infections effectively. For example, some STAT1 gain-of-function changes are linked to difficulty fighting fungal infections.
Does a GOF or LOF label prove that a variant causes disease?
No. The label describes how the protein may behave, while a clinical classification reflects the evidence that the exact genetic variant causes disease. A Variant of Uncertain Significance (VUS) should not alone be used to change treatment or decide on family testing.
Why can loss of function lead to an overactive immune response?
Some immune proteins act as brakes that keep signaling under control. If a mutation removes that brake, the pathway can become overactive even though the mutation is technically a loss of function; this is one mechanism involved in Activated PI3K-delta Syndrome.
How should I interpret a gain- or loss-of-function result on my genetic test?
Ask whether the exact variant is classified as Pathogenic, Likely Pathogenic, or a Variant of Uncertain Significance (VUS), and what laboratory evidence supports its effect. An immunologist and certified genetic counselor should compare the result with your infection, inflammation, autoimmune, family, and inheritance history before recommending changes to care.

Get notified when new evidence is published on Primary immunodeficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (14)
  1. 1

    JAK-STAT signaling pathway, immunodeficiency, inflammation, immune dysregulation, and inborn errors of immunity.

    Samra S, Bergerson JRE, Freeman AF, Turvey SE

    The Journal of allergy and clinical immunology 2025; (155(2)):357-367 doi:10.1016/j.jaci.2024.09.020.

    PMID: 39369964
  2. 2

    Biallelic loss-of-function PTPN6 variants lead to inflammatory lung disease and hemolytic anemia.

    Moussavi-Harami SF, Zinter MS, Motta M, et al.

    The Journal of experimental medicine 2026; (223(11)) doi:10.1084/jem.20252379.

    PMID: 42841903
  3. 3

    IRF and STAT Transcription Factors - From Basic Biology to Roles in Infection, Protective Immunity, and Primary Immunodeficiencies.

    Mogensen TH

    Frontiers in immunology 2018; (9()):3047 doi:10.3389/fimmu.2018.03047.

    PMID: 30671054
  4. 4

    One Gene, Many Facets: Multiple Immune Pathway Dysregulation in SOCS1 Haploinsufficiency.

    Körholz J, Gabrielyan A, Sowerby JM, et al.

    Frontiers in immunology 2021; (12()):680334 doi:10.3389/fimmu.2021.680334.

    PMID: 34421895
  5. 5

    Hyperactivation of the PI3K pathway in inborn errors of immunity: current understanding and therapeutic perspectives.

    IJspeert H, Dalm VASH, van Zelm MC, Edwards ESJ

    Immunotherapy advances 2024; (4(1)):ltae009 doi:10.1093/immadv/ltae009.

    PMID: 39679264
  6. 6

    JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study.

    Fischer M, Olbrich P, Hadjadj J, et al.

    The Journal of allergy and clinical immunology 2024; (153(1)):275-286.e18 doi:10.1016/j.jaci.2023.10.018.

    PMID: 37935260
  7. 7

    Inborn errors of human transcription factors governing IFN-γ antimycobacterial immunity.

    Ogishi M, Yang R, Rosain J, et al.

    Current opinion in immunology 2023; (81()):102296 doi:10.1016/j.coi.2023.102296.

    PMID: 36867972
  8. 8

    PI3Kδ and primary immunodeficiencies.

    Lucas CL, Chandra A, Nejentsev S, et al.

    Nature reviews. Immunology 2016; (16(11)):702-714 doi:10.1038/nri.2016.93.

    PMID: 27616589
  9. 9

    Activated phosphoinositide 3-kinase delta syndrome: Pathogenesis, clinical manifestations, and treatment.

    Zhu K, Li Q, Han L, Sun J

    Pediatric discovery 2024; (2(3)):e2504 doi:10.1002/pdi3.2504.

    PMID: 40625457
  10. 10

    Genetic screening in a Brazilian cohort with inborn errors of immunity.

    Ferreira CS, Francisco Junior RDS, Gerber AL, et al.

    BMC genomic data 2023; (24(1)):47 doi:10.1186/s12863-023-01148-z.

    PMID: 37592284
  11. 11

    Genetic Counseling in Pediatric Inborn Errors of Immunity: Perspective Piece on Current Practice and Considerations.

    DeBortoli E, McInerney-Leo A, Macintosh R, et al.

    The journal of allergy and clinical immunology. In practice 2025; (13(8)):1918-1927 doi:10.1016/j.jaip.2025.03.052.

    PMID: 40252833
  12. 12

    Clinical description, genetic analysis and characterization of two NLRP12 heterozygous VUS variants.

    Lizama-Muñoz A, Gutiérrez-Bautista JF, García-Aznar JM, et al.

    Frontiers in immunology 2026; (17()):1755711 doi:10.3389/fimmu.2026.1755711.

    PMID: 42099593
  13. 13

    Exome and genome sequencing for inborn errors of immunity.

    Meyts I, Bosch B, Bolze A, et al.

    The Journal of allergy and clinical immunology 2016; (138(4)):957-969 doi:10.1016/j.jaci.2016.08.003.

    PMID: 27720020
  14. 14

    Somatic mosaicism in genetic errors of immunity.

    Cooper MA

    The Journal of allergy and clinical immunology 2025; (155(3)):759-767 doi:10.1016/j.jaci.2024.11.038.

    PMID: 39724970

This page explains gain-of-function and loss-of-function mutations for informational purposes only and does not constitute medical advice. An immunologist and certified genetic counselor should interpret your exact variant and advise on care.